Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 6MMW | Q00959 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMX | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMX | Q00959 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MN7 | Q2N0S6 | Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment | Envelope Glycoprotein gp120, Envelope Glycoprotein gp41, BF520.1 Fab variable region |
| 6MN7 | Q2N0S7 | Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment | Envelope Glycoprotein gp120, Envelope Glycoprotein gp41, BF520.1 Fab variable region |
| 6MN7 | 6MN7 | Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment | Envelope Glycoprotein gp120, Envelope Glycoprotein gp41, BF520.1 Fab variable region |
| 6MNA | O53780 | Crystal structure of LpqN involved in cell envelope biogenesis of Mycobacterium tuberculosis | |
| 6MNF | 6MNF | Anti-HIV-1 Fab 2G12 + Man8 re-refinement | |
| 6MNV | A0A2K2R2Z1 | Crystal structure of X. citri phosphoglucomutase in complex with CH2FG1P | |
| 6MOY | B3DQP5 | Crystal structure of the E257A mutant of BlMan5B in complex with GlcNAc (co-crystallization) | |
| 6MOZ | P04062 | Structure of acid-beta-glucosidase in complex with an aromatic pyrrolidine iminosugar inhibitor | |
| 6MP0 | P01887 | Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with the TRP1-M9 peptide | |
| 6MP0 | P01899 | Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with the TRP1-M9 peptide | |
| 6MP0 | P07147 | Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with the TRP1-M9 peptide | |
| 6MP1 | P01887 | Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with the mutant TRP1-K8 peptide | |
| 6MP1 | P01899 | Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with the mutant TRP1-K8 peptide | |
| 6MP1 | P07147 | Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with the mutant TRP1-K8 peptide | |
| 6MP6 | Q15758 | Cryo-EM structure of the human neutral amino acid transporter ASCT2 | Neutral amino acid transporter B(0) |
| 6MP7 | B3DQP5 | Crystal structure of the E257A mutant of BlMan5B in complex with GlcNAc (soaking) | |
| 6MPA | B3DQP5 | Crystal structure of BlMan5B in complex with GlcNAc (soaking) | |
| 6MPB | Q15758 | Cryo-EM structure of the human neutral amino acid transporter ASCT2 | Neutral amino acid transporter B(0) |
| 6MPG | Q2N0S6 | Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | A12V163-b.01 Light Chain, Envelope glycoprotein gp41, Envelope glycoprotein gp120, A12V163-b.01 Heavy Chain, PGT122 Heavy chain, PGT122 Light chain, VRC03 heavy chain, VRC03 Light chain |
| 6MPG | 6MPG | Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | A12V163-b.01 Light Chain, Envelope glycoprotein gp41, Envelope glycoprotein gp120, A12V163-b.01 Heavy Chain, PGT122 Heavy chain, PGT122 Light chain, VRC03 heavy chain, VRC03 Light chain |
| 6MPG | Q2N0S7 | Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | A12V163-b.01 Light Chain, Envelope glycoprotein gp41, Envelope glycoprotein gp120, A12V163-b.01 Heavy Chain, PGT122 Heavy chain, PGT122 Light chain, VRC03 heavy chain, VRC03 Light chain |
| 6MPH | 6MPH | Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | DF1W-a.01 heavy chain, DF1W-a.01 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 heavy chain, PGT122 Light Chain, VRC03 Heavy chain, VRC03 Light Chain |
| 6MPH | Q2N0S7 | Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | DF1W-a.01 heavy chain, DF1W-a.01 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 heavy chain, PGT122 Light Chain, VRC03 Heavy chain, VRC03 Light Chain |
| 6MPH | Q2N0S6 | Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | DF1W-a.01 heavy chain, DF1W-a.01 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 heavy chain, PGT122 Light Chain, VRC03 Heavy chain, VRC03 Light Chain |
| 6MPL | O70632 | Racemic M2-TM I39A crystallized from racemic detergent | |
| 6MPM | O70632 | Racemic M2-TM I42A crystallized from racemic detergent | Matrix protein 2 |
| 6MPN | O70632 | Racemic M2-TM I42E crystallized from racemic detergent | Matrix protein 2 |
| 6MRV | 6MRV | Sialidase26 co-crystallized with DANA | |
| 6MSL | P06756 | Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D | |
| 6MSL | P05106 | Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D | |
| 6MSL | 6MSL | Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D | |
| 6MSS | 6MSS | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | A11B8.2 NKT TCR alpha-chain, A11B8.2 NKT TCR beta-chain, Antigen-presenting glycoprotein CD1d1, Beta-2-microglobulin |
| 6MSS | P11609 | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | A11B8.2 NKT TCR alpha-chain, A11B8.2 NKT TCR beta-chain, Antigen-presenting glycoprotein CD1d1, Beta-2-microglobulin |
| 6MSS | P01887 | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | A11B8.2 NKT TCR alpha-chain, A11B8.2 NKT TCR beta-chain, Antigen-presenting glycoprotein CD1d1, Beta-2-microglobulin |
| 6MSU | P06756 | Integrin alphaVBeta3 in complex with EETI-II 2.5F | |
| 6MSU | P05106 | Integrin alphaVBeta3 in complex with EETI-II 2.5F | |
| 6MSU | 6MSU | Integrin alphaVBeta3 in complex with EETI-II 2.5F | |
| 6MSY | P0DOX5 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | P0DOX5 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | P0DOX7 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | P0DOX7 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MTJ | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
| 6MTJ | 6MTJ | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
| 6MTN | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
| 6MTN | 6MTN | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
